Ulcerative Colitis after Administration of Dupilumab, an Anti-interleukin-4 Receptor Subunit α Monoclonal Antibody.

Saved in:
Bibliographic Details
Title: Ulcerative Colitis after Administration of Dupilumab, an Anti-interleukin-4 Receptor Subunit α Monoclonal Antibody.
Authors: Mamizu H; Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan., Mamizu M; Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan., Ishikawa D; Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan., Kawakami H; Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan., Furukawa T; Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan., Ishida T; Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan., Sakai T; Department of Diagnostic Pathology, Niigata Prefectural Central Hospital, Japan.
Source: Internal medicine (Tokyo, Japan) [Intern Med] 2026 Jun 01; Vol. 65 (11), pp. 1505-1508. Date of Electronic Publication: 2025 Oct 23.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1349-7235
DOI:10.2169/internalmedicine.5953-25